鬱血性心臟衰竭治療器材市場規模、佔有率及成長分析：依產品類型、治療方法、模式、病患類型、最終用戶和地區分類－2026-2033年產業預測

2024 年全球鬱血性心臟衰竭治療設備市場價值為 62 億美元，預計到 2025 年將成長至 65.5 億美元，到 2033 年將成長至 102 億美元，預測期（2026-2033 年）的複合年成長率為 5.69%。

全球鬱血性心臟衰竭治療設備市場受到心臟衰竭盛行率不斷上升的顯著影響，尤其是在老年人和慢性病患者中。這推動了對創新器械治療方法的需求，包括植入式系統，例如心臟再同步治療裝置和左心室輔助裝置（LVAD），以及遠端監測解決方案。這些治療方法不僅有助於降低住院率和死亡率，還能減輕醫療保健系統的經濟負擔。該領域正朝著微創治療和增強遠距醫療能力的方向發展，重點在於整合遠距監測和數據分析。這一趨勢有助於及時進行臨床干預，從而鼓勵保險公司提供報銷支持，激勵製造商探索人工智慧創新，並最終提高新興市場的可及性。

全球鬱血性心臟衰竭治療設備市場的成長要素

全球鬱血性心臟衰竭設備市場的發展主要得益於設備設計、材料、感測器技術和電池壽命方面的顯著進步，這些進步共同提升了安全性、有效性和患者舒適度。監測功能、精準治療和簡化植入手術的創新，增強了醫療專業人員的信心，也提高了病患的接受度。隨著醫療機構擴大採用這些設備，整體市場需求不斷成長，從而創造了鼓勵對新治療方法研發進行更多投資和創新的環境。這一趨勢正在對不同地區的各種醫療機構產生積極影響，改善了鬱血性心臟衰竭患者獲得有效治療的機會。

全球鬱血性心臟衰竭設備市場面臨的限制因素

由於先進的心臟衰竭治療設備及其持續維護高成本，全球鬱血性心臟衰竭治療設備市場面臨許多限制因素。這些經濟障礙不僅阻礙了資源匱乏的醫療機構採用這些設備，還可能使保險公司的報銷核准流程複雜化。因此，醫院和臨床醫生可能會推遲採購這些設備的決策，從而限制患者獲得治療的機會，尤其是那些保險覆蓋不足的患者。此外，在報銷環境波動和預算驅動的採購模式下，醫院可能會選擇更具成本效益或更為保守的治療方法，而不是以設備為主導的治療方法，這可能會對市場滲透率和商業化採購慣例產生負面影響。

全球鬱血性心臟衰竭治療設備市場趨勢

全球鬱血性心臟衰竭治療設備市場正呈現出顯著的趨勢，即採用遠端血流動力學監測技術，包括植入式和穿戴式感測器。這一轉變正在改變慢性心臟衰竭的管理方式，實現持續的生理追蹤，並為臨床醫生提供關鍵訊息，從而有效調整治療方案。遠距監測和遠端保健平台的整合，透過提高患者參與度並最大限度地減少面對面就診的需求，支持了全面的護理路徑。隨著保險公司和醫療服務提供者認知到協同護理的價值，設備開發商越來越注重確保互通性、患者舒適度和可操作的決策支持，以最佳化治療效果並提高患者的生活品質。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球鬱血性心臟衰竭治療設備市場規模：依產品類型分類

• 心室輔助裝置（VAD）
  • 左心室輔助裝置（LVAD）
  • 右心室輔助裝置（RVAD）
  • 雙心室輔助裝置（BiVAD）
• 植入式心臟整流去顫器（ICD）
  • 經靜脈植入式心律轉復除顫器
  • 皮下植入式心臟復律去顫器
• 心臟再同步治療（CRT）裝置
  • CRT-D（心臟去心房顫動）
  • CRT心律調節器（CRT-P）
• 心律調節器
  • 植入式心臟節律器
  • 體外心律調節器
• 主動脈內球囊反搏幫浦（IABP）
• 體外膜氧合（ECMO）系統
• 全人工心臟（TAH）
• 遠端心臟衰竭監測設備
• 其他心臟衰竭支援設備

全球鬱血性心臟衰竭治療設備市場規模：依治療類型分類

• 機械循環輔助
• 節律管理療法
• 心臟再同步治療
• 血流動力學監測
• 臨時心臟輔助性治療

全球鬱血性心臟衰竭設備市場規模：依治療方式分類

• 植入式裝置
• 外部設備

全球鬱血性心臟衰竭治療設備市場規模：依患者類型分類

• 急性心臟衰竭
• 慢性心臟衰竭
• 末期心臟衰竭

全球鬱血性心臟衰竭設備市場規模：依最終用戶分類。

• 醫院
• 心臟護理中心
• 門診手術中心
• 專科診所

全球鬱血性心臟衰竭治療設備市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Medtronic plc
• Abbott Laboratories
• Boston Scientific Corporation
• BIOTRONIK SE & Co. KG
• Abiomed
• LivaNova PLC
• Terumo Corporation
• MicroPort Scientific Corporation
• Getinge AB
• Edwards Lifesciences Corporation
• Teleflex Incorporated
• B. Braun SE
• Jarvik Heart, Inc.
• Berlin Heart GmbH
• Syncardia Systems, LLC
• OSYPKA Medical GmbH
• Oscor Inc.
• Shree Pacetronix Ltd.
• Calon Cardio-Technology Ltd.
• EBR Systems, Inc.

結論與建議

Global Congestive Heart Failure Treatment Devices Market size was valued at USD 6.2 Billion in 2024 and is poised to grow from USD 6.55 Billion in 2025 to USD 10.2 Billion by 2033, growing at a CAGR of 5.69% during the forecast period (2026-2033).

The global market for congestive heart failure treatment devices is significantly influenced by the increasing prevalence of heart failure, particularly among aging populations and those burdened by chronic diseases. This has led to a heightened demand for innovative device-based therapies, including implantable systems like cardiac resynchronization therapy devices and left ventricular assist devices, as well as remote monitoring solutions. These interventions not only help reduce hospitalizations and mortality rates but also alleviate financial strains on healthcare systems. The sector is transitioning towards minimal invasiveness and enhanced remote care capabilities, emphasizing the integration of remote monitoring and data analytics. This trend allows for timely clinical interventions, thereby fostering payer support for reimbursement and driving manufacturers to explore AI innovations, ultimately expanding access in emerging markets.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Congestive Heart Failure Treatment Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Congestive Heart Failure Treatment Devices Market Segments Analysis

Global congestive heart failure treatment devices market is segmented by product type, therapy type, modality, patient type, end user and region. Based on product type, the market is segmented into Ventricular Assist Devices (VADs), Implantable Cardioverter Defibrillators (ICDs), Cardiac Resynchronization Therapy (CRT) Devices, Pacemakers, Intra-Aortic Balloon Pumps (IABP), Extracorporeal Membrane Oxygenation (ECMO) Systems, Total Artificial Hearts (TAH), Remote Heart Failure Monitoring Devices and Other Heart Failure Support Devices. Based on therapy type, the market is segmented into Mechanical Circulatory Support, Rhythm Management Therapy, Cardiac Resynchronization Therapy, Hemodynamic Monitoring and Temporary Cardiac Support Therapy. Based on modality, the market is segmented into Implantable Devices and External Devices. Based on patient type, the market is segmented into Acute Heart Failure, Chronic Heart Failure and End-Stage Heart Failure. Based on end user, the market is segmented into Hospitals, Cardiac Care Centers, Ambulatory Surgical Centers and Specialty Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Congestive Heart Failure Treatment Devices Market

The Global Congestive Heart Failure Treatment Devices market is driven by significant advancements in device design, materials, sensor technology, and battery life, which collectively improve safety, effectiveness, and patient comfort. Innovations in monitoring capabilities, precise delivery of treatments, and the simplicity of implant procedures contribute to heightened confidence among healthcare professionals and greater acceptance from patients. As healthcare providers increasingly adopt these devices, the overall market demand rises, fostering an environment that encourages further investments and innovations in the creation of new treatments. This dynamic positively impacts various care settings across different regions, enhancing access to effective therapies for congestive heart failure.

Restraints in the Global Congestive Heart Failure Treatment Devices Market

The Global Congestive Heart Failure Treatment Devices market faces significant limitations due to the high costs associated with advanced heart failure devices and their ongoing maintenance. These financial obstacles can hinder adoption in resource-constrained facilities, as well as complicate the reimbursement approval process for payers. Consequently, such challenges may slow down decision-making among hospitals and clinicians regarding the procurement of these devices, leading to reduced patient accessibility, particularly for those with insufficient insurance coverage. Furthermore, hospitals may opt for more cost-effective or conservative treatment approaches instead of device-centric therapies, negatively impacting market penetration and commercialization opportunities amid fluctuating reimbursement landscapes and budget-driven procurement practices.

Market Trends of the Global Congestive Heart Failure Treatment Devices Market

The Global Congestive Heart Failure Treatment Devices market is experiencing a significant trend towards the adoption of remote hemodynamic monitoring technologies, including implantable and wearable sensors. This shift is transforming chronic heart failure management by enabling continuous physiological tracking and providing clinicians with essential insights to tailor therapies effectively. The integration of remote monitoring with telehealth platforms enhances patient engagement and minimizes the necessity for in-person visits, supporting comprehensive care pathways. As payers and providers recognize the value of coordinated care, device developers are increasingly focusing on ensuring interoperability, patient comfort, and actionable decision support to optimize outcomes and improve quality of life for patients.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Congestive Heart Failure Treatment Devices Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Ventricular Assist Devices (VADs)
  • Left Ventricular Assist Devices (LVADs)
  • Right Ventricular Assist Devices (RVADs)
  • Bi-Ventricular Assist Devices (BiVADs)
• Implantable Cardioverter Defibrillators (ICDs)
  • Transvenous ICDs
  • Subcutaneous ICDs
• Cardiac Resynchronization Therapy (CRT) Devices
  • CRT-Defibrillators (CRT-D)
  • CRT-Pacemakers (CRT-P)
• Pacemakers
  • Implantable Pacemakers
  • External Pacemakers
• Intra-Aortic Balloon Pumps (IABP)
• Extracorporeal Membrane Oxygenation (ECMO) Systems
• Total Artificial Hearts (TAH)
• Remote Heart Failure Monitoring Devices
• Other Heart Failure Support Devices

Global Congestive Heart Failure Treatment Devices Market Size by Therapy Type & CAGR (2026-2033)

• Market Overview
• Mechanical Circulatory Support
• Rhythm Management Therapy
• Cardiac Resynchronization Therapy
• Hemodynamic Monitoring
• Temporary Cardiac Support Therapy

Global Congestive Heart Failure Treatment Devices Market Size by Modality & CAGR (2026-2033)

• Market Overview
• Implantable Devices
• External Devices

Global Congestive Heart Failure Treatment Devices Market Size by Patient Type & CAGR (2026-2033)

• Market Overview
• Acute Heart Failure
• Chronic Heart Failure
• End-Stage Heart Failure

Global Congestive Heart Failure Treatment Devices Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Cardiac Care Centers
• Ambulatory Surgical Centers
• Specialty Clinics

Global Congestive Heart Failure Treatment Devices Market Size & CAGR (2026-2033)

• North America (Product Type, Therapy Type, Modality, Patient Type, End User)
  • US
  • Canada
• Europe (Product Type, Therapy Type, Modality, Patient Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Therapy Type, Modality, Patient Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Therapy Type, Modality, Patient Type, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Therapy Type, Modality, Patient Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIOTRONIK SE & Co. KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abiomed
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jarvik Heart, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Berlin Heart GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syncardia Systems, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OSYPKA Medical GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oscor Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shree Pacetronix Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Calon Cardio-Technology Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EBR Systems, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations